EnteroBiotix
Develops full-spectrum microbiome therapeutics for gastrointestinal diseases including IBS
£19MSeries B
Role not disclosedTB
Thairm Bio
Activity from announced rounds
Activity in this selectionkibo-invest-dd1f3d80
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $25.7M 1 disclosed · full round size, not this investor’s share